| Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients TL Sørensen, M Tani, J Jensen, V Pierce, C Lucchinetti, VA Folcik, S Qin, ... The Journal of clinical investigation 103 (6), 807-815, 1999 | 1184 | 1999 |
| Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. M Andersson, J Alvarez-Cermeno, G Bernardi, I Cogato, P Fredman, ... Journal of Neurology, Neurosurgery & Psychiatry 57 (8), 897-902, 1994 | 898 | 1994 |
| MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ... The Lancet Neurology 15 (3), 292-303, 2016 | 894 | 2016 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 669 | 2009 |
| Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors HBW Larsson, M Stubgaard, JL Frederiksen, M Jensen, O Henriksen, ... Magnetic Resonance in Medicine 16 (1), 117-131, 1990 | 528 | 1990 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 442 | 2019 |
| Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis PS Sorensen, C Ross, KM Clemmesen, K Bendtzen, JL Frederiksen, ... The Lancet 362 (9391), 1184-1191, 2003 | 439 | 2003 |
| Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ... The Lancet Neurology 16 (10), 797-812, 2017 | 401 | 2017 |
| MRI criteria for MS in patients with clinically isolated syndromes X Montalban, M Tintore, J Swanton, F Barkhof, F Fazekas, M Filippi, ... Neurology 74 (5), 427-434, 2010 | 388 | 2010 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 325 | 2015 |
| Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ... The Lancet Neurology 15 (6), 574-584, 2016 | 317 | 2016 |
| Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open … R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ... The Lancet Neurology 17 (5), 405-415, 2018 | 264 | 2018 |
| Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria S Schippling, LJ Balk, F Costello, P Albrecht, L Balcer, PA Calabresi, ... Multiple sclerosis journal 21 (2), 163-170, 2015 | 251 | 2015 |
| In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis HBW Larsson, C Thomsen, J Frederiksen, M Stubgaard, O Henriksen Magnetic resonance imaging 10 (1), 7-12, 1992 | 251 | 1992 |
| Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS F Sellebjerg, L Börnsen, M Khademi, M Krakauer, T Olsson, ... Neurology 73 (23), 2003-2010, 2009 | 246 | 2009 |
| Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017 | 236 | 2017 |
| Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI SP Cramer, H Simonsen, JL Frederiksen, E Rostrup, HBW Larsson NeuroImage: Clinical 4, 182-189, 2014 | 202 | 2014 |
| A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis À Rovira, J Swanton, M Tintoré, E Huerga, F Barkhof, M Filippi, ... Archives of neurology 66 (5), 587-592, 2009 | 196 | 2009 |
| 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis MP Wattjes, O Ciccarelli, DS Reich, B Banwell, N de Stefano, C Enzinger, ... The Lancet Neurology 20 (8), 653-670, 2021 | 195 | 2021 |
| Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS F Sellebjerg, JL Frederiksen, PM Nielsen, J Olesen Neurology 51 (2), 529-534, 1998 | 194 | 1998 |
